Tenderwize
Wróć do wyszukiwania

Développement CMC, synthèse, formulation et fourniture de matériel R&D pour un candidat-médicament

Université de Tours·Tours, France·EUR 150k·Expired · Jul 16, 2026·Open·Services
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

France – Research and experimental development services – Développement CMC, synthèse, formulation et fourniture de matériel R&D pour un candidat-médicament

50/100

Ocena szansy

Needs reviewMedium complexity
ServicesExpired
Skąd ta ocena?

Szansa

50 / 100

Złożoność

60 / 100

Czynniki ryzyka

The stated duration of 1 month is likely insufficient for CMC development, synthesis, formulation, and supply. The noti...

No eligibility criteria, required documents, or selection criteria are provided in the notice. This increases uncertain...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • EUR 150k estimated value
  • Services contract
  • 1 lot
  • Duration 1 MONTH
  • CMC development of a drug candidate
  • Synthesis of R&D material
Pokaż pełne podsumowanie

This tender by Université de Tours seeks CMC development, synthesis, formulation, and supply of R&D material for a drug candidate. It is a single-lot open procedure with an estimated value of €150,000 EUR (maximum budget). Submission is electronic, in French, by 16 July 2026. Award criteria are 30% price and 70% technical quality. Duration is indicated as 1 month but noted as non-binding.

Ryzyka

The stated duration of 1 month is likely insufficient for CMC development, synthesis, formulation, and supply. The noti...

No eligibility criteria, required documents, or selection criteria are provided in the notice. This increases uncertain...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • No variants allowed

Administrative

  • Submission in French language only
  • Electronic submission via Otwórz portal

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Prix — 30%Valeur technique — 70%

Zamawiający

Lokalizacja

Tours, FRA

Identyfikator

19370800500478

Działalność

Education

Części (1)

LOT-0001

Développement CMC, synthèse, formulation et fourniture de matériel R&D pour un candidat-médicament

CMC development, synthesis, formulation, and supply of R&D material for a drug candidate. Place of performance: Tours, France.

ServicesEU fundedElectronic submission

EUR 150k

Szacowana wartość

Lokalizacja

Tours, France

Czas trwania

1 MONTH

Kategoria

Research

Kryteria udzielenia

Prix; Valeur technique

Termin

Expired Jul 16, 2026

Szczegóły zamówienia

Data publikacji
11 Jun 2026
Języki
French

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
405989-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Spain – Research and experimental development services – Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO)

Oct 9

Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases

Sep 2

Belgium – Research and experimental development services – Long-term API stockpiling and rapid finished dose form manufacture

Sep 21

Norway – Research and development services and related consultancy services – Preventive conversations as a means of the police ́s preventive work.

Sep 8

Germany – Research and experimental development services – Toolkit für aktives Verteilnetzmanagement

Aug 31

Norway – Research and development services and related consultancy services – Evaluation of the police's national efforts against criminal networks.

Sep 10